Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation

Results of ARI-0001 CART19 Cells in Patients With Chronic Lymphocytic Leukemia and Richter’s Transformation

CART19 cells are emerging as an alternative therapy for patients with chronic lymphocytic leukemia (CLL). Here we report the outcome of nine consecutive patients with CLL treated with ARI-0001 CART19 cells, six of them with Richter’s transformation (RT). One patient with RT never received therapy. T...

Full description

Bibliographic Details
Main Authors: Valentín Ortiz-Maldonado, Gerard Frigola, Marta Español-Rego, Olga Balagué, Nuria Martínez-Cibrián, Laura Magnano, Eva Giné, Mariona Pascal, Juan G. Correa, Alexandra Martínez-Roca, Joan Cid, Miquel Lozano, Neus Villamor, Daniel Benítez-Ribas, Jordi Esteve, Armando López-Guillermo, Elías Campo, Álvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Oncology
Subjects:
CLL
CART
CD19
DLBCL
Richter disease
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.828471/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.828471/full

Similar Items